NGN-401

· Neurogene Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NGN-401, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome [Phase 3]